
- Mount Sinai Doctors
Lili Chan, MD
Internal Medicine, Nephrology
About Me
Dr. Lili Chan is an Associate Professor in the Department of Medicine, Division of Nephrology at the Icahn School of Medicine at Mount Sinai. She is board certified in Internal Medicine and Nephrology. After graduating from Rutgers University with a degree in Molecular Biology and Biochemistry she went on to complete her medical degree at Drexel University College of Medicine. Dr. Chan completed her internship and residency at Rutgers University Robert Wood Johnson Medical School and her fellowship at Icahn School of Medicine at Mount Sinai.
Dr. Chan cares for patients with a variety of renal conditions ranging from acute kidney injury to end stage renal disease. In addition to patient care, she is an active member of the research community with a focus on examining and identifying methods to improve outcomes in patient requiring renal replacement therapy.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Nephrology
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- Acute Kidney Injury
- End Stage Renal Disease
Education
MD, Drexel University College of Medicine
Residency, Internal Medicine
Rutgers Robert Wood Johnson Medical School
Fellowship, Nephrology
Mount Sinai Hospital
Certifications
American Board of Internal Medicine
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- A distributional reinforcement learning model for optimal glucose control after cardiac surgery. Jacob M. Desman, Zhang Wei Hong, Moein Sabounchi, Ashwin S. Sawant, Jaskirat Gill, Ana C. Costa, Gagan Kumar, Rajeev Sharma, Arpeta Gupta, Paul McCarthy, Veena Nandwani, Doug Powell, Alexandra Carideo, Donnie Goodwin, Sanam Ahmed, Umesh Gidwani, Matthew A. Levin, Robin Varghese, Farzan Filsoufi, Robert Freeman, Avniel Shetreat-Klein, Alexander W. Charney, Ira Hofer, Lili Chan, David Reich, Patricia Kovatch, Roopa Kohli-Seth, Monica Kraft, Pulkit Agrawal, John A. Kellum, Girish N. Nadkarni, Ankit Sakhuja. npj Digital Medicine
- Electronic clinical decision support system guided blood culture stewardship in emergency departments: response to the national blood culture media shortage. Kullaya Takkavatakarn, Gopi Patel, Wonsuk Oh, Melissa Gitman, Michael Nowak, Brendan Connell, Jonathan Nover, Lili Chan, Girish Nadkarni, Roopa Kohli-Seth, Nicholas Gavin, Bernard Camins, Ankit Sakhuja. Infection Control and Hospital Epidemiology
- Peripheral Transcriptomics in Acute and Long-Term Kidney Dysfunction in SARS-CoV-2 Infection. Pushkala Jayaraman, Madhumitha Rajagopal, Ishan Paranjpe, Mayte Suarez-Farinas, Lora E. Liharska, Ryan C. Thompson, Diane Marie Del Valle, Noam D. Beckmann, Anina N. Lund, Pooja Gownivaripally, Wonsuk Oh, Faris F. Gulamali, Justin Kauffman, Edgar Gonzalez-Kozlova, Sergio Dellepiane, George Vasquez-Rios, Akhil Vaid, Joy Jiang, Ben Fox, Ankit Sakhuja, Steven Chen, Ephraim Kenigsberg, John Cijiang He, Steven G. Coca, Lili Chan, Miram Merad, Seunghee Kim-Schulze, Sacha Gnjatic, Ephraim L. Tsalik, Raymond Langley, Alexander W. Charney, Girish N. Nadkarni. Kidney360
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Chan during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Nipro
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.